| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 133 |
| 1 | ASPIRIN | 102 |
| 2 | ASPIRIN 325 MG | 88 |
| 3 | ASPIRIN 81 MG | 88 |
| 4 | PREDNISONE | 73 |
| 5 | METHOTREXATE SODIUM | 70 |
| 6 | ACETAMINOPHEN | 68 |
| 7 | METHOTREXATE | 67 |
| 8 | ADALIMUMAB | 65 |
| 9 | INFLIXIMAB | 65 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLIMUMAB | 51 | 0.0040 |
| 1 | AMIVANTAMAB-VMJW | 5 | 0.0014 |
| 2 | PIROXICAM | 6 | 0.0009 |
| 3 | QUININE | 7 | 0.0008 |
| 4 | CLADRIBINE | 8 | 0.0008 |
| 5 | BLEOMYCIN SULFATE | 8 | 0.0008 |
| 6 | DESLORATADINE | 8 | 0.0007 |
| 7 | VIBEGRON | 6 | 0.0007 |
| 8 | KETOPROFEN | 9 | 0.0007 |
| 9 | RIVAROXABAN | 133 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 1 | Lipid Emulsion [EPC] | 2 | 0.0008 |
| 2 | Factor Xa Inhibitor [EPC] | 164 | 0.0006 |
| 3 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 4 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 3 | 0.0004 |
| 5 | Aminosalicylate [EPC] | 40 | 0.0004 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 53 | 0.0004 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 53 | 0.0004 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 9 | Calcitonin [EPC] | 1 | 0.0003 |